Table 1. Demographic and clinical characteristics of HF patients in California, 2007 and 2010.

		Black		Hispanic		White		Total Sample				All Male		All Female
Factors		2007	2010	2007	2010	2007	2010	2007 HF	2007 Non-HF	2010 HF	2010 Non-HF	2010 HF	2010 Non-HF	2010 HF	2010 Non-HF
n		8,400	8,279	11,769	12,762	38,375	36,178	58,544	13,241	57,219	21,071	29,090	7,824	28,129	13,241
Col. →		1	2	3	4	5	6	7	8	9	10	11	12	13	14
Female %		51.7	50.0	50.3	49.3	50.3	48.9	50.5	54.4	49.2	50.7	50.8	48.7	49.2	51.3
Age	Mean	63	64	69	69	76	76	73	72	73	66	70	64	76	68
	SD	15.46	15.3	14.94	15.0	13.50	13.6	14.2	14.5	14.9	16.3	15.0	15.8	14.2	16.6
HTN %		92	93	89	90	82	84	85a	77	87a	70	86a	69	88a	72
DM %		51	51	64	64	41	40	47a	39	47a	30	48a	30	46a	30
CHOL %		14	10	6	13	14	11	14a	11	11	7	10	7	11	8
CHD %		53	51	61	60	64	60	62a	40	60a	41	65a	45	55a	37
MI %		9	9	11	10	11	10	10a	4	10	8	10	8	9	7
STRK %		13	13	13	11	12	11	13	14	12	12	11	12	12	12
AFib %		44	45	47	47	62	63	56a	51	57a	43	58a	46	55a	39
CKD %		49	56	49	54	40	48	43a	22	50a	21	53a	22	47a	19
COPD %		38	37	31	30	41	39	38a	24	37a	17	37a	17	36a	17

a. differences between HF and non-HF cases are significant at P<.001.

SD, standard deviation; HTN, hypertension; DM, diabetes mellitus; CHOL, high cholesterol; CHD, coronary heart disease; MI, myocardial infarction; STRK, stroke; AFib, atrial fibrillation; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.

Non-HF category excluded all patients with any diagnosis of HF.